Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Neurobiology of Disease|August 19, 2021
Prolonged NCX activation prevents SOD1 accumulation, reduces neuroinflammation, ameliorates motor behavior and prolongs survival in a ALS mouse modelSerenella Anzilotti, Valeria Valsecchi, Paola Brancaccio, et al.
ACS Chemical Neuroscience|July 15, 2015
Neuroprotective Effect of VEGF-Mimetic Peptide QK in Experimental Brain Ischemia Induced in Rat by Middle Cerebral Artery OcclusionGiuseppe Pignataro, Barbara Ziaco, Anna Tortiglione, et al.
ACS Pharmacology & Translational Science|July 18, 2024
Newly Synthesized Indolylacetic Derivatives Reduce Tumor Necrosis Factor-Mediated Neuroinflammation and Prolong Survival in Amyotrophic Lateral Sclerosis MiceAngela Corvino, Giuseppe Caliendo, Ferdinando Fiorino, et al.
Molecular Therapy. Nucleic Acids|February 21, 2024
Anti-miRNA103/107 encapsulated in transferrin-conjugated lipid nanoparticles crosses blood-brain barrier and reduces brain ischemic damagePasquale Cepparulo, Ornella Cuomo, Virginia Campani, et al.
Iscience|February 16, 2024
Metabolic rewiring and autophagy inhibition correct lysosomal storage disease in mucopolysaccharidosis IIIBMelania Scarcella, Gianluca Scerra, Mariangela Ciampa, et al.
Frontiers in Neuroscience|August 23, 2018
Ionic Homeostasis Maintenance in ALS: Focus on New Therapeutic TargetsRossana Sirabella, Valeria Valsecchi, Serenella Anzilotti, et al.
ACS Pharmacology & Translational Science|February 19, 2026
Correction to "Newly Synthesized Indolylacetic Derivatives Reduce Tumor Necrosis Factor-Mediated Neuroinflammation and Prolong Survival in Amyotrophic Lateral Sclerosis Mice"Angela Corvino, Giuseppe Caliendo, Ferdinando Fiorino, et al.
Pharmacological Research|November 4, 2024
Nanoparticles encapsulating phosphatidylinositol derivatives promote neuroprotection and functional improvement in preclinical models of ALS via a long-lasting activation of TRPML1 lysosomal channelValentina Tedeschi, Valeria Nele, Valeria Valsecchi, et al.
Cell Death & Disease|February 14, 2018
Preconditioning, induced by sub-toxic dose of the neurotoxin L-BMAA, delays ALS progression in mice and prevents Na+/Ca2+ exchanger 3 downregulationSerenella Anzilotti, Paola Brancaccio, Giuseppe Simeone, et al.
Theranostics|April 14, 2025
A new nano-encapsulated TSPO ligand reduces neuroinflammation and improves cognitive functions in Alzheimer's disease modelAntonella Casamassa, Paola Brancaccio, Virginia Campani, et al.
Pageof 5